New Report Highlights Public Health Risks from Diagnostic Error
An estimated 795,000 Americans die or are permanently disabled by diagnostic error each year, according to a new analysis of national data.
Read More
Search Results for: lung cancer
AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Read More
Lung Cancer Mortality Risk Predicted by Blood Test
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read More
PARIS Test Finds Unexpected Cancer Treatment Options
By testing a range of therapies in organoids grown from the patient’s own tumor sample, SEngine’s PARIS Test identified off-label therapy that proved highly successful for one ovarian cancer patient.
Read More
Breath Biopsy Test for Lung Cancer in Development
Owlstone Medical announced new data on the development of a breath biopsy screening test for the early detection of lung cancer.
Read More